Gyros Protein Technologies

Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab xPand and Gyrolab xPloreTM), and peptide synthesis (PurePep Chorus, Symphony X and PurePep Sonata+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell & gene therapies and vaccines. Gyros Protein Technologies is a division of Mesa Laboratories

Immunoassays in the biotherapeutic workflow,peptide synthesis for academic and industrial applications,biologics pk immunoassays,host cell impurity immunoassays,bioprocessing impurity immunoassays,clinical pk immunoassays,automated miniaturized elisas,and cell & gene therapy

Gyros protein technologies operates in the Biotechnology research industry.

Gyros protein technologies's revenue is 11m - 100m

Gyros protein technologies has 51 - 200 employees.